Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 02 1997, 394-400, Vol 41, No. 2
PJ Tummino, PJ Harvey, T McQuade, J Domagala, R Gogliotti, J Sanchez, Y Song and D Hupe
It has been shown previously by our group and others that a series of four
disulfide benzamides with cellular anti-human immunodeficiency virus (HIV)
activity can eject zinc from HIV type 1 nucleocapsid protein (NCp7) in
vitro while analogs without antiviral activity do not. We also found that
the zinc ejection activity correlates with the loss of the ability of NCp7
to bind to HIV psi RNA in vitro. These observations indicate that the
antiviral disulfide benzamides may act at a novel retroviral target of
action, i.e., the nucleocapsid protein. The present studies examine the
relationship among disulfide benzamide structure, in vitro NCp7 zinc
ejection activity, and antiviral activity for a larger series of compounds.
All of the antiviral disulfide benzamides were found to eject NCp7 zinc,
while some disulfide benzamides with zinc ejection activity are not
antiviral. Utilizing the thiol reagent 5,5'-dithiobis(2-nitrobenzoic acid),
it was determined that the o-amido-phenyl disulfides being studied cyclize
in aqueous solution to form benzisothiazolones. A series of
benzisothiazolones, which are stable in solution in the absence of
dithiothreitol, were found to eject NCp7 zinc at a rate similar to that of
their disulfide benzamide analogs and to possess similar antiviral
activity. It was also found that the relative rates of HIV inactivation by
various disulfide benzamides and benzisothiazolones correlate with their
relative kinetic rates of NCp7 zinc ejection, which is consistent with the
nucleocapsid protein being the target of action of these compounds.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
The human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein zinc ejection activity of disulfide benzamides and benzisothiazolones: correlation with anti-HIV and virucidal activities
Department of Biochemistry, Parke-Davis Pharmaceutical Research, Ann Arbor, Michigan 48105, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»